{"news_desk": "Science", "print_page": "2", "section_name": "Health", "subsection_name": null, "byline": {"contributor": "", "original": "By GINA KOLATA", "person": [{"rank": 1, "role": "reported", "firstname": "Gina", "organization": "", "lastname": "KOLATA"}]}, "abstract": "Cholesterol-lowering drug Praluent, developed by Sanofi and Regeneron Pharmaceuticals, is extraordinarily powerful 'game changer' in fight against LDL cholesterol for nearly a million Americans with inherited condition that causes resistance to cholesterol-lowering statins; extremely high cost of Praluent, nearly $14,600 a year, is causing insurance companies to set stringent requirements for its use.", "type_of_material": "News", "word_count": "1113", "lead_paragraph": "About a million Americans have an inherited condition that defies cholesterol-lowering statins. Even at $14,600 a year, a new drug provides hope.", "pub_date": "2015-07-28T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Praluent Looks Cheap to Those With Extreme Cholesterol", "print_headline": "When $14,600 for a Drug Looks Cheap"}, "snippet": "About a million Americans have an inherited condition that defies cholesterol-lowering statins. Even at $14,600 a year, a new drug provides hope.", "multimedia": [{"height": 126, "url": "images/2015/07/28/science/28HEART1/28HEART1-thumbWide-v2.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/07/28/science/28HEART1/28HEART1-thumbWide-v2.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/07/28/science/28HEART1/28HEART1-articleLarge-v2.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/07/28/science/28HEART1/28HEART1-articleLarge-v2.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/07/28/science/28HEART1/28HEART1-thumbStandard-v2.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/07/28/science/28HEART1/28HEART1-thumbStandard-v2.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/07/28/health/praluent-looks-cheap-to-those-with-extreme-cholesterol.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Cholesterol", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Regeneron Pharmaceuticals Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Statins (Cholesterol-Lowering Drugs)", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Sanofi SA", "name": "organizations"}, {"rank": "5", "is_major": "Y", "value": "Heart", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Praluent (Drug)", "name": "subject"}], "blog": [], "_id": "55b6a2e838f0d860ec81db35", "source": "The New York Times"}